Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CONCENTRIX SREV, INC. (SREV)
|
Add to portfolio |
|
|
|
| Price: |
$1.04
| | Metrics |
| OS: |
99.9
|
M
| |
-16
|
% ROE
|
| Market cap: |
$104
|
M
| |
-13
|
% ROIC
|
|
Net cash:
|
$19.5
|
M
| |
$0.20
|
per share
|
|
EV:
|
$84.4
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$2.2
|
M
| |
37.6
|
x EV/EBITDA
|
|
EBIT
|
($8.6)
|
M
| |
|
|
| EPS |
($0.10)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 195.7 | 194.6 | 216.1 | 238.3 | 239.1 | 252.9 | 252.2 | 272.2 |
| Revenue growth | 0.6% | -10.0% | -9.3% | -0.3% | -5.4% | 0.3% | -7.3% | -0.1% |
| Cost of goods sold | 140.0 | 137.0 | 153.2 | 164.7 | 163.7 | 165.1 | 171.4 | 194.0 |
| Gross profit | 55.7 | 57.6 | 63.0 | 73.6 | 75.4 | 87.8 | 80.8 | 78.2 |
| Gross margin | 28.5% | 29.6% | 29.1% | 30.9% | 31.5% | 34.7% | 32.1% | 28.7% |
| Sales and marketing | 17.1 | 25.0 | 30.0 | 35.6 | 33.0 | 42.0 | 44.1 | 60.0 |
| Research and development | 5.2 | 5.6 | 4.8 | 6.4 | 5.7 | 8.3 | 16.5 | 25.8 |
| General and administrative | 45.1 | 42.0 | 43.2 | 47.3 | 53.1 | 53.0 | 46.3 | 47.8 |
| EBITA | -10.6 | -13.6 | -13.2 | -13.4 | -11.8 | -14.0 | -22.0 | -52.6 |
| EBITA margin | -5.4% | -7.0% | -6.1% | -5.6% | -4.9% | -5.5% | -8.7% | -19.3% |
| Amortization of intangibles | | | | 1.8 | 1.5 | 1.5 | 1.5 | 1.9 |
| EBIT | -10.6 | -13.6 | -13.2 | -15.2 | -13.3 | -15.5 | -23.5 | -54.5 |
| EBIT margin | -5.4% | -7.0% | -6.1% | -6.4% | -5.6% | -6.1% | -9.3% | -20.0% |
| Pre-tax income | -14.4 | -17.8 | -18.2 | -24.4 | -31.5 | -28.7 | -39.0 | -94.9 |
| Income taxes | 0.3 | 0.7 | 0.4 | 0.5 | -1.6 | 3.4 | 1.6 | 0.5 |
| Tax rate | | | | | 5.2% | | | |
| Net income | -14.7 | -18.5 | -18.7 | -24.9 | -29.8 | -32.1 | -40.6 | -95.3 |
| Net margin | -7.5% | -9.5% | -8.6% | -10.4% | -12.5% | -12.7% | -16.1% | -35.0% |
| |
| Diluted EPS | ($0.15) | ($0.19) | ($0.20) | ($0.27) | ($0.33) | ($0.37) | ($0.48) | ($1.15) |
| Shares outstanding (diluted) | 98.1 | 95.8 | 93.9 | 91.6 | 89.2 | 86.3 | 85.4 | 82.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|